Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Acoramidis Efficacy in ATTR-CM Genotypes
Added: 5 months ago Source:  Radcliffe Cardiology
New analyses from the ATTRibute-CM trial show that the transthyretin (TTR) stabiliser acoramidis provides consistent clinical benefits in patients with both wild-type (ATTRwt-CM) and variant (ATTRv-CM) transthyretin amyloid cardiomyopathy.1 The findings include data from the main 30-month trial and its ongoing 42-month open-label extension (OLE).Acoramidis is an orally administered, small… View more

Inherited and Congenital Cardiac Conditions

Heart Failure
Guideline-directed Medical Therapy is the Most Effective Decongestion
Author(s): Jelena Celutkiene , Alexandre Mebazaa , Jan Biegus , et al Added: 1 year ago

Heart Failure
Research Area(s) / Expertise: Job title: Interventional Cardiologist
Dr Paul Sorajja is an Interventional Cardiologist at the Banner Health in Phoenix, Arizona.Dr Sorajja's clinical practice specialises in interventional cardiology, with a focus on catheter-based therapy of valvular and structural heart disease. He was part of the team that performed the first transcatheter mitral valve replacement in the US for a patient with native mitral regurgitation in 2015,… View more
EASD 25: EMPIRE-PREVENT: Metabolic Effects of Empagliflozin in Patients at Risk of Heart Failure
Author(s): Camilla Andersen Added: 6 months ago
EASD Congress 2025 - Dr Camilla Andersen (The University of Western Australia, Perth, AU) joins us to discuss findings from the EMPIRE-PREVENT: Metabolic study, investigating the metabolic effects of empagliflozin in elderly and obese patients at high risk of developing heart failure (HF).This randomized controlled trial evaluated 165 patients aged 60–84 years with obesity (BMI >28kg/m²) and… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
COVID-19 and Cardiovascular Care in Asia-Pacific
Author(s): Mitsuaki Sawano , Misato Chimura , Jonathan Yap , et al Added: 1 year ago

Imaging & Diagnostics

Prevention & Chronic Conditions
Biomarkers for Congestion in Heart Failure
Author(s): Antonio Luca Maria Parlati , Cristina Madaudo , Vincenzo Nuzzi , et al Added: 1 year ago

Heart Failure
Cardiomyopathy and Gender Disparities in South Asia
Author(s): Khalida Soomro , David Tak Wai Lui , Rungroj Krittayaphong , et al Added: 4 months ago

Demographic

Heart Failure
Phenotypes of Myocardial Dysfunction on Serial Echocardiography and CMR in Women With Early-Stage Breast Cancer
Author(s): Dan Lenihan, Flora Huang, Jose Alvarez-Cardona Start date: Oct 02, 2025
Join Dr Dan Lenihan (Saint Francis Healthcare System, US), Dr Flora Huang (North York General Hospital, CA) and Dr Jose Álvarez Cardona (New York University School of Medicine, US) for this month's Journal Club where they will discuss phenotypes of myocardial dysfunction on serial echocardiography and CMR in women with early-stage breast cancer.This expert-led webinar explores mechanisms of… View more

Imaging & Diagnostics

CV Disease in Special Populations
MAPLE-HCM: Aficamten Outperforms Beta-Blocker in Obstructive Hypertrophic Cardiomyopathy
Added: 7 months ago Source:  Radcliffe Cardiology
Two phase 3 trials presented at the European Society of Cardiology Congress 2025 have provided new insights into the role of myosin inhibitors for hypertrophic cardiomyopathy (HCM), with one trial demonstrating superiority over standard care in obstructive HCM and another failing to meet its primary endpoints in the non-obstructive form of the disease.¹˒²The MAPLE-HCM trial found that the cardiac… View more

Guidelines & Statements

Heart Failure
SGLTi and GLP-1 in HF
Author(s): Jose L Batista , Tracy Makuvire , Jonathan D Davis , et al Added: 11 months ago

Cardiovascular Renal Metabolic

Heart Failure